LEADER 03269nam  22006135  450 
001 9910842096403321
005 20241120175050.0
010   $a9783031482847
010   $a3031482840
024 7 $a10.1007/978-3-031-48284-7
035   $a(CKB)30597552500041
035   $a(DE-He213)978-3-031-48284-7
035   $a(MiAaPQ)EBC31727443
035   $a(Au-PeEL)EBL31727443
035   $a(OCoLC)1424862284
035   $a(EXLCZ)9930597552500041
100   $a20240222d2024      u|         0
101 0 $aeng
135   $aur|||||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aToward Good Simulation Practice $eBest Practices for the Use of Computational Modelling and Simulation in the Regulatory Process of Biomedical Products /$fedited by Marco Viceconti, Luca Emili
205   $a1st ed. 2024.
210  1$aCham :$cSpringer Nature Switzerland :$cImprint: Springer,$d2024.
215   $a1 online resource (X, 144 p. 19 illus., 12 illus. in color.) 
225 1 $aSynthesis Lectures on Biomedical Engineering,$x1930-0336
311 08$a9783031482830 
311 08$a3031482832 
327   $aIntroduction -- Theoretical foundations of Good Simulation Practice -- Model development -- Model credibility -- Possible regulatory pathways -- Possible Health Technology Assessment pathways -- Ethical review of in silico methodologies -- The sponsor -- The investigator: modellers and analysts.
330   $aThis open access book, the Community of Practice led by the VPH Institute, the Avicenna Alliance, and the In Silico World consortium has brought together 138 experts in In Silico Trials working in academia, the medical industry, regulatory bodies, hospitals, and consulting firms. Through a consensus process, these experts produced the first attempt to define some Good Simulation Practices on how to develop, evaluate, and use In Silico Trials. Good Simulation Practice constitutes an indispensable guide for anyone who is planning to engage at any title with In Silico Trials. This book is open access, which means that you have free and unlimited access. Offers readers a unique guide to In Silico Trials Documents consensus process run by the most authoritative organizations worldwide in the field Represents the first attempt to produce a consensus position on the best practice for In Silico Trials.
410  0$aSynthesis Lectures on Biomedical Engineering,$x1930-0336
606   $aBiomedical engineering
606   $aBioethics
606   $aComputer simulation
606   $aBiomedical Engineering and Bioengineering
606   $aBioethics
606   $aComputer Modelling
615  0$aBiomedical engineering.
615  0$aBioethics.
615  0$aComputer simulation.
615 14$aBiomedical Engineering and Bioengineering.
615 24$aBioethics.
615 24$aComputer Modelling.
676   $a610.28
702   $aViceconti$b Marco$4edt$4http://id.loc.gov/vocabulary/relators/edt
702   $aEmili$b Luca$4edt$4http://id.loc.gov/vocabulary/relators/edt
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910842096403321
996   $aToward Good Simulation Practice$94146875
997   $aUNINA